RADICAVA ORS® (edaravone) Now Available in the U.S. for the Treatment of ALS
RADICAVA ORS gives people with ALS an oral treatment option that offers the same efficacy as the IV formulation of edaravone1 JERSEY CITY, N.J., June …
radicava®
Mitsubishi Tanabe Pharma America Presents Real-World Data on RADICAVA® (edaravone) at 2022 American Academy of Neurology Annual Meeting
Analysis Suggests Use of RADICAVA IV is Associated with Improved Survival in People with ALS JERSEY CITY, N.J., April 4, 2022 — Mitsubishi Tanabe …